New hope for Lewy Body Dementia
When Debbie Seplow lost her husband Andy in 2019, it was the end of a journey that began some 15 years earlier when he first developed what she describes as odd behaviors, depression and hallucinations. Andy suffered from Lewy Body Dementia, an aggressive and incurable brain disorder that is the second-leading cause of dementia but is not well understood—and is often misdiagnosed.
FDA Approves First Alzheimer’s Drug in 18 Years
Earlier this week, the Food and Drug Administration announced a landmark approval of Biogen's aducanumab, the first new drug to slow Alzheimer’s disease in nearly two decades and the first drug attacking the underlying pathobiology. The Banner Alzheimer’s Institute was a primary site involved in one of the pivotal phase 3 studies of aducanamab.